Abbott Challenges Biosimilar Legality
This from today's Xconomy. Abbott has filed a citizen's petition with the FDA to protect Humira by challenging the notion that the agency can refer to Abbott's Humira BLA filing. Their argument (posted here and here before) is that this would violate..
Original Article: Abbott Challenges Biosimilar LegalityNEXT ARTICLE